372 related articles for article (PubMed ID: 16205722)
1. Evidence that the plant cannabinoid Delta9-tetrahydrocannabivarin is a cannabinoid CB1 and CB2 receptor antagonist.
Thomas A; Stevenson LA; Wease KN; Price MR; Baillie G; Ross RA; Pertwee RG
Br J Pharmacol; 2005 Dec; 146(7):917-26. PubMed ID: 16205722
[TBL] [Abstract][Full Text] [Related]
2. The psychoactive plant cannabinoid, Delta9-tetrahydrocannabinol, is antagonized by Delta8- and Delta9-tetrahydrocannabivarin in mice in vivo.
Pertwee RG; Thomas A; Stevenson LA; Ross RA; Varvel SA; Lichtman AH; Martin BR; Razdan RK
Br J Pharmacol; 2007 Mar; 150(5):586-94. PubMed ID: 17245367
[TBL] [Abstract][Full Text] [Related]
3. Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist.
Cascio MG; Gauson LA; Stevenson LA; Ross RA; Pertwee RG
Br J Pharmacol; 2010 Jan; 159(1):129-41. PubMed ID: 20002104
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship for the endogenous cannabinoid, anandamide, and certain of its analogues at vanilloid receptors in transfected cells and vas deferens.
Ross RA; Gibson TM; Brockie HC; Leslie M; Pashmi G; Craib SJ; Di Marzo V; Pertwee RG
Br J Pharmacol; 2001 Feb; 132(3):631-40. PubMed ID: 11159715
[TBL] [Abstract][Full Text] [Related]
5. Effects of Delta9-tetrahydrocannabivarin on [35S]GTPgammaS binding in mouse brain cerebellum and piriform cortex membranes.
Dennis I; Whalley BJ; Stephens GJ
Br J Pharmacol; 2008 Jul; 154(6):1349-58. PubMed ID: 18493244
[TBL] [Abstract][Full Text] [Related]
6. Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
Thomas A; Baillie GL; Phillips AM; Razdan RK; Ross RA; Pertwee RG
Br J Pharmacol; 2007 Mar; 150(5):613-23. PubMed ID: 17245363
[TBL] [Abstract][Full Text] [Related]
7. Evidence that (-)-7-hydroxy-4'-dimethylheptyl-cannabidiol activates a non-CB(1), non-CB(2), non-TRPV1 target in the mouse vas deferens.
Pertwee RG; Thomas A; Stevenson LA; Maor Y; Mechoulam R
Neuropharmacology; 2005 Jun; 48(8):1139-46. PubMed ID: 15910889
[TBL] [Abstract][Full Text] [Related]
8. (-)-Cannabidiol antagonizes cannabinoid receptor agonists and noradrenaline in the mouse vas deferens.
Pertwee RG; Ross RA; Craib SJ; Thomas A
Eur J Pharmacol; 2002 Dec; 456(1-3):99-106. PubMed ID: 12450575
[TBL] [Abstract][Full Text] [Related]
9. The plant cannabinoid Delta9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice.
Bolognini D; Costa B; Maione S; Comelli F; Marini P; Di Marzo V; Parolaro D; Ross RA; Gauson LA; Cascio MG; Pertwee RG
Br J Pharmacol; 2010 Jun; 160(3):677-87. PubMed ID: 20590571
[TBL] [Abstract][Full Text] [Related]
10. O-1057, a potent water-soluble cannabinoid receptor agonist with antinociceptive properties.
Pertwee RG; Gibson TM; Stevenson LA; Ross RA; Banner WK; Saha B; Razdan RK; Martin BR
Br J Pharmacol; 2000 Apr; 129(8):1577-84. PubMed ID: 10780961
[TBL] [Abstract][Full Text] [Related]
11. The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
Pertwee RG
Br J Pharmacol; 2008 Jan; 153(2):199-215. PubMed ID: 17828291
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain.
Breivogel CS; Griffin G; Di Marzo V; Martin BR
Mol Pharmacol; 2001 Jul; 60(1):155-63. PubMed ID: 11408610
[TBL] [Abstract][Full Text] [Related]
13. Structural determinants of the partial agonist-inverse agonist properties of 6'-azidohex-2'-yne-delta8-tetrahydrocannabinol at cannabinoid receptors.
Ross RA; Gibson TM; Stevenson LA; Saha B; Crocker P; Razdan RK; Pertwee RG
Br J Pharmacol; 1999 Oct; 128(3):735-43. PubMed ID: 10516656
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
Lay L; Angus JA; Wright CE
Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cannabinoid binding sites in guinea-pig forebrain and small intestine.
Ross RA; Brockie HC; Fernando SR; Saha B; Razdan RK; Pertwee RG
Br J Pharmacol; 1998 Nov; 125(6):1345-51. PubMed ID: 9863666
[TBL] [Abstract][Full Text] [Related]
16. Anandamide-mediated CB1/CB2 cannabinoid receptor--independent nitric oxide production in rabbit aortic endothelial cells.
McCollum L; Howlett AC; Mukhopadhyay S
J Pharmacol Exp Ther; 2007 Jun; 321(3):930-7. PubMed ID: 17379772
[TBL] [Abstract][Full Text] [Related]
17. Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors.
Bátkai S; Mukhopadhyay P; Horváth B; Rajesh M; Gao RY; Mahadevan A; Amere M; Battista N; Lichtman AH; Gauson LA; Maccarrone M; Pertwee RG; Pacher P
Br J Pharmacol; 2012 Apr; 165(8):2450-61. PubMed ID: 21470208
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and characterization of potent and selective agonists of the neuronal cannabinoid receptor (CB1).
Hillard CJ; Manna S; Greenberg MJ; DiCamelli R; Ross RA; Stevenson LA; Murphy V; Pertwee RG; Campbell WB
J Pharmacol Exp Ther; 1999 Jun; 289(3):1427-33. PubMed ID: 10336536
[TBL] [Abstract][Full Text] [Related]
19. Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder.
Pertwee RG; Fernando SR
Br J Pharmacol; 1996 Aug; 118(8):2053-8. PubMed ID: 8864542
[TBL] [Abstract][Full Text] [Related]
20. AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor.
Bolognini D; Cascio MG; Parolaro D; Pertwee RG
Br J Pharmacol; 2012 Apr; 165(8):2561-74. PubMed ID: 21615724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
